Search

Meeting Coverage:

Association for Research in Vision & Ophthalmology

ARVO: 2018

Baseline Features and Treatment Outcomes in Wet AMD

Nathan C. Steinle, MD

Show Description +

Do lesion type and size influence outcomes in patients with wet age-related macular degeneration (AMD)? Nathan C. Steinle, MD, addresses this question in light of integrated data from the VIEW 1 and VIEW 2 post hoc analysis, which looked at lesion type and size across anti-VEGF therapy over 1 year. He suggests that perhaps it's time to look at fluorescein angiography again to better characterize the long-term visual potential of patients.

Posted: 5/01/2018

Keywords:

Age-Related Macular Degeneration (AMD)

•

Anti-VEGF

•

fluorescein angiography, FA

Up Next

Digital Disruptions in Ophthalmology

Digital Disruptions in Ophthalmology

John B. Miller, MD, Roger A. Goldberg, MD, MBA

Getting Better at Treating Diabetic Retinopathy

Getting Better at Treating Diabetic Retinopathy

Nadia K. Waheed, MD, MPH, William F. Mieler, MD

DME Treatment Patterns

DME Treatment Patterns

Jeffrey R. Willis, MD, PhD

Quarterly Dosing and AMD: A Cross-Trial Comparison

Quarterly Dosing and AMD: A Cross-Trial Comparison

David A. Eichenbaum, MD

Real-World Outcomes of nAMD Treated With Anti-VEGF Therapy

Real-World Outcomes of nAMD Treated With Anti-VEGF Therapy

Thomas A. Ciulla, MD, MBA

Results From the STOMP-CSC Trial

Results From the STOMP-CSC Trial

Roger A. Goldberg, MD, MBA

Five-Year Rates of Diabetic Retinopathy Progression

Five-Year Rates of Diabetic Retinopathy Progression

Andrew A. Moshfeghi, MD, MBA

A New Approach to Managing Macular Holes?

A New Approach to Managing Macular Holes?

Daniel Su, MD

A Future Role in Retina for Stem Cell and Gene Therapy?

A Future Role in Retina for Stem Cell and Gene Therapy?

Baruch D. Kuppermann, MD, PhD, Nathan C. Steinle, MD

Predictive Data From the HAWK and HARRIER Studies

Predictive Data From the HAWK and HARRIER Studies

A New Approach to Deviation Mapping for Retinal Perfusion

A New Approach to Deviation Mapping for Retinal Perfusion

Richard B. Rosen, MD

Early Experiences and Outcomes With Pneumatic Retinopexy vs. Future Use

Early Experiences and Outcomes With Pneumatic Retinopexy vs. Future Use

Glenn C. Yiu, MD, PhD

Back to All Videos

Baseline Features and Treatment Outcomes in Wet AMD

Nathan C. Steinle, MD

Do lesion type and size influence outcomes in patients with wet age-related macular degeneration (AMD)? Nathan C. Steinle, MD, addresses this question in light of integrated data from the VIEW 1 and VIEW 2 post hoc analysis, which looked at lesion type and size across anti-VEGF therapy over 1 year. He suggests that perhaps it's time to look at fluorescein angiography again to better characterize the long-term visual potential of patients.

Posted: 5/01/2018

Keywords:

Age-Related Macular Degeneration (AMD)

•

Anti-VEGF

•

fluorescein angiography, FA

Please log in to leave a comment.

More From ARVO: 2018 Coverage

Results From the STOMP-CSC Trial

Results From the STOMP-CSC Trial

Roger A. Goldberg, MD, MBA

Five-Year Rates of Diabetic Retinopathy Progression

Five-Year Rates of Diabetic Retinopathy Progression

Andrew A. Moshfeghi, MD, MBA

A New Approach to Managing Macular Holes?

A New Approach to Managing Macular Holes?

Daniel Su, MD

A Future Role in Retina for Stem Cell and Gene Therapy?

A Future Role in Retina for Stem Cell and Gene Therapy?

Baruch D. Kuppermann, MD, PhD, Nathan C. Steinle, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARVO: 2018.